HIV & AIDS

Experimental HIV vaccine targets virus envelope protein

AIDS research has investigated many strategies to tackle the HIV virus. Now, a new type of vaccine developed within the EU-funded project EuroNeut-41, targets an HIV envelope protein called the gp41. The protein is directly ...

Diseases, Conditions, Syndromes

Vaccine confers long-term protection against cholera

A clinical study published in the Lancet Infectious Diseases shows for the first time that an oral cholera vaccine (ShancholTM) provides sustained protection against cholera in humans for up to five years. The study showed ...

Diseases, Conditions, Syndromes

Pain-free microneedle influenza vaccine is effective, long-lasting

Scientists have developed an influenza vaccine delivered via microneedle patch that provided 100 percent protection against a lethal influenza virus in mice more than one year after vaccination. They report their findings ...

Diseases, Conditions, Syndromes

Rotavirus vaccine given to newborns in Africa is effective

Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration. ...

Medical research

Gut bacteria play key role in vaccination, study finds

The bacteria that live in the human gut may play an important role in immune response to vaccines and infection by wild-type enteric organisms, according to two recent studies resulting from a collaborative effort between ...

Medications

India announces low-cost rotavirus vaccine (Update)

The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world.

page 24 from 35